$9M
Fentanyl Qui Tam False Claims Act
Case results are sourced directly from attorney websites by Injuria.ai's data infrastructure, which actively monitors 22,000+ personal injury law firms. They are not results obtained by ThatCarHitMe.com. Every case is unique and must be evaluated on its own facts. Prior results do not guarantee a similar outcome. The results shown are not necessarily representative of all results obtained by these firms.
Case Details
Settlement against private equity firm Belhealth Investment Partners and its principals and their portfolio companies, Linden Care and Quick Care, for False Claims Act violations. Allegations involved unlawful distribution of Subsys, a potent fentanyl sublingual spray, for widespread off-label, illegitimate, and non-medically accepted uses.
Additional Notes
The United States Department of Justice declined to intervene in the case in 2018. The case is notable for successfully resolving claims against a private equity firm for False Claims Act violations. Case captioned United States ex rel. Jane Doe v. Insys Therapeutics, No. 2:16-cv-7937-JLS-AS (C.D. Cal.).